Table 4.
Demographics, hemodynamics and medical treatment of 75 patients admitted with ADHF.
| Treatment Cohort (n=75) |
|
|---|---|
| Baseline Clinical Data | |
| Age (years) | 57 ± 13 |
| Gender (% male) | 78 |
| Ischemic Etiology (%) | 47 |
| Body Mass Index (kg/m2) | 29 ± 6 |
| Diabetes Mellitus (%) | 44 |
| Left Ventricular EF (%) | 24 ± 13 |
| Atrial Fibrillation (%) | 28 |
| Baseline Hemodynamic Data | |
| Heart Rate Baseline (bpm) | 87 ± 18 |
| Mean arterial pressure Baseline (mmHg) | 82 ± 13 |
| Mean RA pressure Baseline (mmHg) | 18 ± 6 |
| Mean PA pressure Baseline (mmHg) | 43 ± 9 |
| PCWP Baseline (mmHg) | 31 ± 7 |
| Fick Cardiac index Baseline (L/min/m2) | 1.84 ± 0.64 |
| Follow-up Hemodynamic Data | |
| Heart Rate FU (bpm) | 86 ± 15 |
| Mean arterial pressure FU (mmHg) | 75 ± 8 |
| Mean RA pressure FU (mmHg) | 9 ± 9 |
| Mean PA pressure FU (mmHg) | 29 ± 6 |
| PCWP FU (mmHg) | 16 ± 5 |
| Fick Cardiac index FU (L/min/m2) | 2.67 ± 0.83 |
| Medications | |
| ACE inhibitor or ARBs (%) | 72 |
| Beta-blockers (%) | 72 |
| Loop diuretics (%) | 99 |
| Aldosterone antagonists (%) | 56 |
| Nitroprusside (%) | 75 |
| Hydralazine (%) | 74 |
| Isosorbide Dinitrate (%) | 66 |
| Milrinone (%) | 28 |
| Dobutamine (%) | 24 |
| IABP (%) | 7 |
| Device Data | |
| ICD (%) | 59 |
| CRT-D (%) | 21 |
| Laboratory Data | |
| Creatinine (mg/dl) | 1.52 ± 0.69 |
Abbreviations as in Table 1.
FU = follow-up (time of catheter removal)